Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H PORTER

Showing results (431-440 of 885) with videos related to

Pageof 89
Sort By:
The Journal of Pharmacy and Pharmacology|February 9, 2002
Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic productsLeab Sek, Christopher J H Porter, Ann Marie Kaukonen, et al.
Neurotoxicology|January 1, 1995
Hydroxyl radical generation in rat brain is initiated by iron but not aluminum, as determined by microdialysis with salicylate trapping and GC-MS analysisC X Xie, J St Pyrek, W H Porter, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 18, 2000
Inhibition of TNF-alpha production contributes to the attenuation of LPS-induced hypophagia by pentoxifyllineM H Porter, B J Hrupka, G Altreuther, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1994
Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletionR H Porter, J G Greene, D S Higgins, et al.
Genetics|September 1, 2014
Hybrid incompatibility arises in a sequence-based bioenergetic model of transcription factor bindingAlexander Y Tulchinsky, Norman A Johnson, Ward B Watt, et al.
Analytical Biochemistry|May 1, 1985
An o-phthalaldehyde spectrophotometric assay for proteinasesF C Church, D H Porter, G L Catignani, et al.
Drug Intelligence & Clinical Pharmacy|February 1, 1988
Cyclosporine binding to components in medication administration setsM D Parr, S D Barton, V M Haver, et al.
Journal of Pharmaceutical Sciences|April 18, 2014
Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: effect of drug type and formulation composition on in vitro pharmaceutical performanceHywel D Williams, Michiel Van Speybroeck, Patrick Augustijns, et al.
Medical & Biological Engineering|September 1, 1974
Developments in apparatus for dynamic in vitro testing of human muscle. Part 1. Mechanical design, environment control and stimulationD F Fay, N B Jones, N H Porter, et al.
Drug Delivery and Translational Research|March 20, 2015
Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administrationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Pageof 89

Showing results (431-440 of 885) with videos related to

Sort By:
Pageof 89
The Journal of Pharmacy and Pharmacology|February 9, 2002
Evaluation of the in-vitro digestion profiles of long and medium chain glycerides and the phase behaviour of their lipolytic productsLeab Sek, Christopher J H Porter, Ann Marie Kaukonen, et al.
Neurotoxicology|January 1, 1995
Hydroxyl radical generation in rat brain is initiated by iron but not aluminum, as determined by microdialysis with salicylate trapping and GC-MS analysisC X Xie, J St Pyrek, W H Porter, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|November 18, 2000
Inhibition of TNF-alpha production contributes to the attenuation of LPS-induced hypophagia by pentoxifyllineM H Porter, B J Hrupka, G Altreuther, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 1, 1994
Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletionR H Porter, J G Greene, D S Higgins, et al.
Genetics|September 1, 2014
Hybrid incompatibility arises in a sequence-based bioenergetic model of transcription factor bindingAlexander Y Tulchinsky, Norman A Johnson, Ward B Watt, et al.
Analytical Biochemistry|May 1, 1985
An o-phthalaldehyde spectrophotometric assay for proteinasesF C Church, D H Porter, G L Catignani, et al.
Drug Intelligence & Clinical Pharmacy|February 1, 1988
Cyclosporine binding to components in medication administration setsM D Parr, S D Barton, V M Haver, et al.
Journal of Pharmaceutical Sciences|April 18, 2014
Lipid-based formulations solidified via adsorption onto the mesoporous carrier Neusilin® US2: effect of drug type and formulation composition on in vitro pharmaceutical performanceHywel D Williams, Michiel Van Speybroeck, Patrick Augustijns, et al.
Medical & Biological Engineering|September 1, 1974
Developments in apparatus for dynamic in vitro testing of human muscle. Part 1. Mechanical design, environment control and stimulationD F Fay, N B Jones, N H Porter, et al.
Drug Delivery and Translational Research|March 20, 2015
Nanostructured reverse hexagonal liquid crystals sustain plasma concentrations for a poorly water-soluble drug after oral administrationTri-Hung Nguyen, Tracey Hanley, Christopher J H Porter, et al.
Pageof 89